常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.23/0.48
|
|
企業價值
2.80B
|
| 資產負債 |
|
每股賬面淨值
-0.57
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
489.68M
|
|
每股收益
0.20
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world byimproving access to treatments for various diseases. |

5.3 
